Immune cells in the kidneys may influence high blood pressure and salt sensitivity.

Kidney-resident memory CD8+ T cells promote hypertension and memorize salt sensitivity.

NIH-funded research Univ of Arkansas for Med Scis · NIH-10995201

This study is looking at how certain immune cells in the kidneys might affect high blood pressure and how your body handles salt, with the goal of finding new ways to help people manage their hypertension better.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniv of Arkansas for Med Scis NIH-funded
Lab location1 site (Little Rock, United States)
Project IDNIH-10995201 on NIH RePORTER

What this research studies

This research investigates how specific immune cells, known as kidney-resident memory CD8+ T cells, contribute to high blood pressure and the body's response to salt. The study aims to understand the mechanisms by which these immune cells interact with kidney functions, particularly how they may lead to excessive salt retention and hypertension. By exploring the relationship between these immune cells and blood pressure regulation, the research seeks to uncover new insights that could improve treatment strategies for hypertension. Patients may benefit from a better understanding of how their immune system affects their blood pressure and potential new therapies targeting these immune responses.

Who could benefit from this research

Good fit: Ideal candidates for this research are adults suffering from hypertension, particularly those who experience salt sensitivity.

Not a fit: Patients with hypertension that is not influenced by immune responses or those who do not have salt sensitivity may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments for hypertension that address the underlying immune mechanisms.

How similar studies have performed: While the role of immune cells in hypertension is a growing area of interest, this specific approach focusing on kidney-resident memory CD8+ T cells is relatively novel and has not been extensively tested.

Where this research is happening

Little Rock, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.